Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sihai Li

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Human Vaccines & Immunotherapeutics|January 26, 2017
Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjectsNianmin Shi, Yibin Zhang, Huizhen Zheng, et al.
Science Bulletin|March 9, 2026
Immunogenicity and safety of an Escherichia coli-produced 9-valent HPV vaccine in adolescents aged 9 to17 compared with young womenYulin Jing, Xiaowen Hu, Li Zhang, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Human Vaccines & Immunotherapeutics|January 26, 2017
Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjectsNianmin Shi, Yibin Zhang, Huizhen Zheng, et al.
Science Bulletin|March 9, 2026
Immunogenicity and safety of an Escherichia coli-produced 9-valent HPV vaccine in adolescents aged 9 to17 compared with young womenYulin Jing, Xiaowen Hu, Li Zhang, et al.
Pageof 3